A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia
- PMID: 40936476
- DOI: 10.1111/bjh.70152
A decade of pharmacovigilance in France: Immune checkpoints join the list of usual suspects for drug-induced immune haemolytic anaemia
Keywords: autoimmune haemolytic anaemia; drug adverse events.
References
REFERENCES
-
- Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010;24(4–5):143–150.
-
- Mayer B, Bartolmas T, Yurek S, Salama A. Variability of findings in drug‐induced immune haemolytic anaemia: experience over 20 years in a single Centre. Transfus Med Hemother. 2015;42(5):333–339.
-
- Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol. 2012;87(7):707–709.
-
- Leger RM, Arndt PA, Garratty G. How we investigate drug‐induced immune hemolytic anemia. Immunohematology. 2014;30(2):85–94.
-
- Garratty G, Arndt PA. Drugs that have been shown to cause drug‐induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007. Immunohematology. 2014;30(2):66–79.
LinkOut - more resources
Full Text Sources
